Advertisement

Ads Placeholder
Loading...

INOVIQ Ltd

IIQ.AXASX
Healthcare
Medical - Diagnostics & Research
$0.34
$0.00(0.00%)
Australian Market opens in 2h 17m

INOVIQ Ltd Fundamental Analysis

INOVIQ Ltd (IIQ.AX) shows weak financial fundamentals with a PE ratio of -5.88, profit margin of -5.95%, and ROE of -37.14%. The company generates $0.0B in annual revenue with weak year-over-year growth of 2.39%.

Key Strengths

Cash Position32.44%
PEG Ratio-4.08
Current Ratio7.56

Areas of Concern

ROE-37.14%
Operating Margin-8.34%
We analyze IIQ.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -433.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-433.5/100

We analyze IIQ.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

IIQ.AX struggles to generate sufficient returns from assets.

ROA > 10%
-29.52%

Valuation Score

Excellent

IIQ.AX trades at attractive valuation levels.

PE < 25
-5.88
PEG Ratio < 2
-4.08

Growth Score

Moderate

IIQ.AX shows steady but slowing expansion.

Revenue Growth > 5%
2.39%
EPS Growth > 10%
12.13%

Financial Health Score

Excellent

IIQ.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
7.56

Profitability Score

Weak

IIQ.AX struggles to sustain strong margins.

ROE > 15%
-3713.81%
Net Margin ≥ 15%
-5.95%
Positive Free Cash Flow
No

Key Financial Metrics

Is IIQ.AX Expensive or Cheap?

P/E Ratio

IIQ.AX trades at -5.88 times earnings. This suggests potential undervaluation.

-5.88

PEG Ratio

When adjusting for growth, IIQ.AX's PEG of -4.08 indicates potential undervaluation.

-4.08

Price to Book

The market values INOVIQ Ltd at 1.91 times its book value. This may indicate undervaluation.

1.91

EV/EBITDA

Enterprise value stands at -6.84 times EBITDA. This is generally considered low.

-6.84

How Well Does IIQ.AX Make Money?

Net Profit Margin

For every $100 in sales, INOVIQ Ltd keeps $-5.95 as profit after all expenses.

-5.95%

Operating Margin

Core operations generate -8.34 in profit for every $100 in revenue, before interest and taxes.

-8.34%

ROE

Management delivers $-37.14 in profit for every $100 of shareholder equity.

-37.14%

ROA

INOVIQ Ltd generates $-29.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-29.52%

Following the Money - Real Cash Generation

Operating Cash Flow

INOVIQ Ltd generates limited operating cash flow of $-4.73M, signaling weaker underlying cash strength.

$-4.73M

Free Cash Flow

INOVIQ Ltd generates weak or negative free cash flow of $-4.81M, restricting financial flexibility.

$-4.81M

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

IIQ.AX converts -12.61% of its market value into free cash.

-12.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-4.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.91

vs 25 benchmark

P/S Ratio

Price to sales ratio

33.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.37

vs 25 benchmark

ROA

Return on assets percentage

-0.30

vs 25 benchmark

ROCE

Return on capital employed

-0.45

vs 25 benchmark

How IIQ.AX Stacks Against Its Sector Peers

MetricIIQ.AX ValueSector AveragePerformance
P/E Ratio-5.8828.45 Better (Cheaper)
ROE-37.14%763.00% Weak
Net Margin-594.92%-45265.00% (disorted) Weak
Debt/Equity0.010.34 Strong (Low Leverage)
Current Ratio7.562795.60 Strong Liquidity
ROA-29.52%-16588.00% (disorted) Weak

IIQ.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews INOVIQ Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

38.63%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

12.94%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

24.88%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ